Close Menu

cell-free DNA

The new European initiative promises to deliver multiple new tests and methods for improving the treatment of breast cancer and rectal cancer.

The company said that it is working on cfDNA claim extensions for various PCR and NGS assays in its portfolio, which would be compatible with the new extraction system.

Labs reported on their work with kits from both Roche and Thermo Fisher, both of which have launched new commercial liquid biopsy products in recent years.

Participants shared data from head-to-head assay comparisons, reflected on the advancement of NGS and digital PCR methods, and discussed new standardization projects.

BUPA Global and other private health insurers have approved reimbursement for OncoDNA's test, which is intended to provide a complete genetic profile of a patient's tumor. 

The final LCD covers AlloSure in renal allograft recipients who have a probability of active renal allograft rejection.

Natera has entered the oncology space with a ctDNA assay and sees its blood banking service as a way to eventually tap into the consumer genomics space. 

Karius' new financing will support clinical trials and commercialization of its NGS-based infectious disease test, and will help scale up laboratory capacity. 

Today's agreement, which covers the UK, follows distribution deals OncoDNA signed earlier this month covering Morocco and Belarus. 

Diagnostics firm BioHisto Maroc will market and distribute the firm's tissue-based and liquid biopsy sequencing services to oncologists and their patients.

Pages